Cubist Systematic Strategies’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $864K | Sell |
51,609
-244,452
| -83% | -$3.66M | ﹤0.01% | 2015 |
|
|
2025
Q2 | $4.25M | Buy |
+296,061
| New | +$4.06M | 0.02% | 1115 |
|
|
2024
Q3 | – | Sell |
-290,336
| Closed | -$2.19M | – | 3296 |
|
|
2024
Q2 | $2.19M | Buy |
290,336
+251,072
| +639% | +$2.08M | 0.01% | 1273 |
|
|
2024
Q1 | $394K | Sell |
39,264
-182,080
| -82% | -$1.69M | ﹤0.01% | 2750 |
|
|
2023
Q4 | $2.06M | Buy |
221,344
+188,002
| +564% | +$1.94M | 0.01% | 1487 |
|
|
2023
Q3 | $424K | Sell |
33,342
-123,891
| -79% | -$1.7M | ﹤0.01% | 2406 |
|
|
2023
Q2 | $2.23M | Buy |
157,233
+64,534
| +70% | +$906K | 0.01% | 1404 |
|
|
2023
Q1 | $1.38M | Sell |
92,699
-91,855
| -50% | -$1.39M | 0.01% | 1935 |
|
|
2022
Q4 | $2.74M | Buy |
184,554
+157,992
| +595% | +$2.58M | 0.02% | 1559 |
|
|
2022
Q3 | $439K | Buy |
26,562
+1,008
| +4% | +$20.3K | ﹤0.01% | 3263 |
|
|
2022
Q2 | $537K | Sell |
25,554
-68,139
| -73% | -$1.39M | ﹤0.01% | 3006 |
|
|
2022
Q1 | $2.2M | Buy |
93,693
+72,545
| +343% | +$1.78M | 0.02% | 1400 |
|
|
2021
Q4 | $575K | Sell |
21,148
-92,520
| -81% | -$2.48M | 0.01% | 2346 |
|
|
2021
Q3 | $3.23M | Buy |
113,668
+35,121
| +45% | +$1.07M | 0.04% | 704 |
|
|
2021
Q2 | $2.37M | Buy |
78,547
+66,631
| +559% | +$1.97M | 0.03% | 979 |
|
|
2021
Q1 | $304K | Sell |
11,916
-43,185
| -78% | -$1.11M | ﹤0.01% | 2243 |
|
|
2020
Q4 | $1.35M | Sell |
55,101
-147,603
| -73% | -$2.77M | 0.02% | 1186 |
|
|
2020
Q3 | $3.3M | Buy |
202,704
+116,149
| +134% | +$2.16M | 0.05% | 608 |
|
|
2020
Q2 | $1.48M | Buy |
86,555
+23,167
| +37% | +$343K | 0.03% | 964 |
|
|
2020
Q1 | $738K | Sell |
63,388
-144,723
| -70% | -$2.98M | 0.02% | 1025 |
|
|
2019
Q4 | $5.78M | Buy |
208,111
+26,954
| +15% | +$676K | 0.11% | 252 |
|
|
2019
Q3 | $4.1M | Buy |
181,157
+23,993
| +15% | +$547K | 0.08% | 359 |
|
|
2019
Q2 | $3.96M | Sell |
157,164
-121,032
| -44% | -$3.25M | 0.07% | 387 |
|
|
2019
Q1 | $7.56M | Buy |
278,196
+217,523
| +359% | +$7.29M | 0.24% | 58 |
|
|
2018
Q4 | $2M | Buy |
60,673
+45,100
| +290% | +$1.81M | 0.09% | 278 |
|
|
2018
Q3 | $727K | Sell |
15,573
-21,643
| -58% | -$994K | 0.04% | 611 |
|
|
2018
Q2 | $1.61M | Buy |
37,216
+34,465
| +1,253% | +$1.65M | 0.08% | 309 |
|
|
2018
Q1 | $153K | Sell |
2,751
-8,859
| -76% | -$486K | 0.01% | 1492 |
|
|
2017
Q4 | $620K | Sell |
11,610
-281
| -2% | -$13.3K | 0.03% | 750 |
|
|
2017
Q3 | $513K | Buy |
11,891
+10,981
| +1,207% | +$522K | 0.03% | 808 |
|
|
2017
Q2 | $55K | Sell |
910
-1,976
| -68% | -$117K | ﹤0.01% | 1535 |
|
|
2017
Q1 | $200K | Buy |
2,886
+98
| +4% | +$6.81K | 0.01% | 1188 |
|
|
2016
Q4 | $186K | Buy |
2,788
+1,329
| +91% | +$86.5K | 0.01% | 1294 |
|
|
2016
Q3 | $97K | Buy |
+1,459
| New | +$99.8K | 0.01% | 1478 |
|
|
2016
Q2 | – | Sell |
-33,697
| Closed | -$2.18M | – | 1802 |
|
|
2016
Q1 | $2.18M | Buy |
33,697
+16,374
| +95% | +$1.09M | 0.12% | 194 |
|
|
2015
Q4 | $1.24M | Sell |
17,323
-58,401
| -77% | -$4.32M | 0.07% | 378 |
|
|
2015
Q3 | $5.82M | Buy |
75,724
+71,729
| +1,795% | +$5.79M | 0.29% | 36 |
|
|
2015
Q2 | $296K | Sell |
3,995
-24,256
| -86% | -$1.75M | 0.01% | 1229 |
|
|
2015
Q1 | $2.05M | Buy |
28,251
+24,957
| +758% | +$1.74M | 0.1% | 260 |
|
|
2014
Q4 | $218K | Sell |
3,294
-14,766
| -82% | -$901K | 0.01% | 1458 |
|
|
2014
Q3 | $990K | Sell |
18,060
-3,592
| -17% | -$204K | 0.06% | 469 |
|
|
2014
Q2 | $1.26M | Buy |
+21,652
| New | +$1.27M | 0.08% | 388 |
|
Other funds holding MD
N
Cubist Systematic Strategies's MD Position: Q3 2025 in Review
Cubist Systematic Strategies reduced its Pediatrix Medical (MD) stake by 83% in Q3 2025, selling an estimated $3.66M and leaving 51,609 shares worth $864K. The position accounts for ﹤0.01% of the portfolio, ranked #2015.
Cubist Systematic Strategies first reported a position in MD in Q2 2014 and has held it in 42 quarters since. The position peaked at $7.56M in Q1 2019. 268 funds tracked by Wall St. Rank hold MD as of Q3 2025.
- Cubist Systematic Strategies held 51,609 shares of Pediatrix Medical worth $864K as of Q3 2025.
- Cubist Systematic Strategies sold 244,452 Pediatrix Medical shares in Q3 2025, an estimated $3.66M.
- Pediatrix Medical made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2015 holding.
- Cubist Systematic Strategies first reported a position in Pediatrix Medical in Q2 2014 and has held it in 42 quarters since.
- Cubist Systematic Strategies's Pediatrix Medical position peaked at $7.56M in Q1 2019.
- 268 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.